Center for Biologics Evaluation and Research (CBER) has suspended the biologics license for Valneva’s Ixchiq (Chikungunya ...

California, USA-based Protagonist Therapeutics yesterday revealed that its rusfertide, a potential first-in-class ...

Eisai and Biogen have announced that the anti-amyloid beta (Aβ) monoclonal antibody Leqembi (lecanemab) was launched in ...

The US Food and Drug Administration (FDA) has broadened the approved use of Amgen’s Repatha (evolocumab) to include adults at ...

The San Diego, USA firm has simultaneously announced that the US Food and Drug Administration (FDA) has granted Orphan Drug ...

US pharm major AbbVie has signed a deal to acquire Gilgamesh Pharmaceuticals’ lead investigational candidate, currently in ...

Swedish drug developer BioArctic shot up 14.5% to 269.20 kronor on the news of a license and collaboration deal with Swiss ...

The US eosinophilic esophagitis (EoE) market is projected to grow from $202 million in 2020 to $1.19 billion in 2030, ...

Russian drugmaker R-Pharm is searching buyers for its flagship factory in Germany in the city of Illertissen, which was ...

The US Food and Drug Administration on Friday revealed it has begun daily publication of adverse event data from the FDA ...

The Roche subsidiary Genentech has broken ground on its newest US production site in Holly Springs, North Carolina, marking ...

US pharma major Eli Lilly’s shares rose 2.6% to $713.69 in early trading today, after it released positive top-line results ...